These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8162217)

  • 1. Sample size requirements for evaluating heart valves with constant risk events.
    Grunkemeier GL; Johnson DM; Naftel DC
    J Heart Valve Dis; 1994 Jan; 3(1):53-8. PubMed ID: 8162217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial.
    Grunkemeier GL; Jin R; Starr A
    Ann Thorac Surg; 2006 Sep; 82(3):776-80. PubMed ID: 16928482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's requirements for in-vivo performance data for prosthetic heart valves.
    Johnson DM; Sapirstein W
    J Heart Valve Dis; 1994 Jul; 3(4):350-5. PubMed ID: 7952304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prosthesis-related complications: first-year annual rates.
    Jamieson WR; Burr LH; Anderson WN; Chambers JB; Gams JP; Dowd CM;
    J Heart Valve Dis; 2002 Nov; 11(6):758-63. PubMed ID: 12479275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's requirements for in-vitro performance data for prosthetic heart valves.
    Johnson DM; Chwirut DJ; Regnault WF
    J Heart Valve Dis; 1994 May; 3(3):228-34. PubMed ID: 8087255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on derivation of sample size requirements for evaluating heart valves with constant risk events.
    Korosteleva O; Lototsky S
    J Heart Valve Dis; 2003 Sep; 12(5):668-9; author reply 669. PubMed ID: 14565724
    [No Abstract]   [Full Text] [Related]  

  • 7. Does the Ross operation fulfil the objective performance criteria established for new prosthetic heart valves?
    Moidl R; Simon P; Aschauer C; Chevtchik O; Kupilik N; Rödler S; Wolner E; Laufer G
    J Heart Valve Dis; 2000 Mar; 9(2):190-4. PubMed ID: 10772035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation and analysis of heart valve substitutes.
    Grunkemeier GL; Anderson WN
    J Heart Valve Dis; 1998 Mar; 7(2):163-9. PubMed ID: 9587856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Standard Cardiovascular implants--Cardiac Valve Prostheses (ISO 5840:1989) and the FDA Draft Replacement Heart Valve Guidance (Version 4.0).
    Nolan SP
    J Heart Valve Dis; 1994 Jul; 3(4):347-9. PubMed ID: 7952303
    [No Abstract]   [Full Text] [Related]  

  • 10. The new FDA guidelines.
    Bodnar E
    J Heart Valve Dis; 1994 May; 3(3):226-7. PubMed ID: 8087254
    [No Abstract]   [Full Text] [Related]  

  • 11. Bayesian stopping guidelines for heart valve premarket approval studies.
    Grunkemeier GL; Wu Y; Wang L; Hamilton C
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2813-7.e1. PubMed ID: 25135236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement.
    Lund O; Bland M
    J Thorac Cardiovasc Surg; 2006 Jul; 132(1):20-6. PubMed ID: 16798297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center outcome analysis of 1,161 patients with St. Jude medical and ATS open pivot mechanical heart valves.
    Bernet FH; Baykut D; Grize L; Zerkowski HR
    J Heart Valve Dis; 2007 Mar; 16(2):151-8. PubMed ID: 17484464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-year comparison of tissue and mechanical valve replacement.
    Khan SS; Trento A; DeRobertis M; Kass RM; Sandhu M; Czer LS; Blanche C; Raissi S; Fontana GP; Cheng W; Chaux A; Matloff JM
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):257-69. PubMed ID: 11479498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen years' clinical experience with the CarboMedics prosthetic heart valve.
    Aagaard J; Tingleff J
    J Heart Valve Dis; 2005 Jan; 14(1):82-8. PubMed ID: 15700441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of new heart valve prostheses: update of objective performance criteria.
    Wu Y; Butchart EG; Borer JS; Yoganathan A; Grunkemeier GL
    Ann Thorac Surg; 2014 Nov; 98(5):1865-74. PubMed ID: 25258160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term experience with the omniscience cardiac valve.
    Teijeira FJ
    J Heart Valve Dis; 1998 Sep; 7(5):540-7. PubMed ID: 9793854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results after aortic valve replacement in patients with congestive heart failure. Homografts vs prosthetic valves.
    Grocott-Mason RM; Lund O; Elwidaa H; Mazhar R; Chandrasakeran V; Mitchell AG; Ilsley C; Khaghani A; Rees A; Yacoub M
    Eur Heart J; 2000 Oct; 21(20):1698-707. PubMed ID: 11032697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.